🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ana Jiménez Ubieto

Hospital Universitario 12 De Octubre

ORCID: 0000-0003-0892-8682

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial”.

Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial

Journal of Clinical Oncology(2022)10.1200/jco.21.02321

N/A

1.9DataRank · unranked

62 citations

Fátima De la Cruz, Ana Jiménez Ubieto, Javier López‐Jiménez, Alejandro Martı́n, María José Terol +18 more

Usability Evaluation of a Noninvasive Neutropenia Screening Device (PointCheck) for Patients Undergoing Cancer Chemotherapy: Mixed Methods Observational Study

Journal of Medical Internet Research(2022)10.2196/37368

N/A

0.368DataRank · unranked

7 citations

Alberto Pablo‐Trinidad, I. Butterworth, Nolan Bell, Ryan Benasutti, Aurélien Bourquard +10 more

Clinical utility of a novel non-invasive technology for monitoring severe neutropenia in anticancer therapy.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e13632

N/A

0.104DataRank · unranked

1 citations

Toshiaki Iwase, Pablo Tolosa, Pablo Justo Jiménez, Antonia Rodríguez Izquierdo, Tycho Baumann +15 more